Skip to main content
OpenTrials
Completed

NCT Number: NCT01890928

Gluconeogenesis Rates and Its Precursors in Pediatric Sepsis

Critically ill children have abnormal utilization of nutrients such as glucose, lipids and protein. Often sick children have increased glucose concentrations in blood. However, the origin of the high glucose has not been determined in these populations. There is a close interrelationship between protein and energy metabolism. An increase in the energy supply will not promote nitrogen retention unless the amino acid supply is adequate, and conversely, an increased amino acid supply will be useless if energy is limiting, hence the importance of adequate protein and energy intake. Our study aims to investigate the protein-energy interactions in critically ill septic children and adolescents with the objective to eventually provide the best nutritional support for these patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sepsis Critical Illness Disease Attributes Glucose Metabolism Disorders Hyperglycemia Infections Inflammation Metabolic Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Systemic Inflammatory Response Syndrome

Age range

5 year–19 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UT Southwestern Medical Center

Dallas, Texas, 75390, United States

About this study

This is an observational study, aimed at exploring:

i) gluconeogenesis rates ii) sources of gluconeogenesis and pyruvate cycling, and iii) protein kinetics in critically ill children and adolescents, and its differences by age group, as well as in comparison to healthy adolescents. The study size will include 45 critically ill septic, pediatric patients (22 children at 5-12 years of age and 23 adolescents' at 13-19 years of age), male and females admitted to the pediatric intensive care unit (PICU) at Children's Medical Center, Dallas. The minimal subject's weight will be 17kg. Additionally, 30 healthy adolescents matched by age, gender, BMI and Tanner stage will be studied at the Clinical Translational Research Center at Zale Lipshy Hospital, to serve as healthy adolescent controls. The number of subjects includes an expected drop out rate of about 20%, in order to obtain 18 patients with complete data in each group. Patients will receive nutritional support as per standard care. This study will yield important knowledge and may lead in the future to changes in the current practice on the management of critically ill pediatric patients in the PICU.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Septic Pediatric Patients:

Inclusion criteria

  • Children age 5-19 years.
  • Diagnosis of severe sepsis diagnosed as clinical sepsis syndrome (requires two of the following criteria):
  • Source of infection
  • Fever or Hypothermia
  • Leukocytosis or Leucopenia
  • Poor organ perfusion (such as delayed capillary refill or decreased urine output or hypotension)
  • Bacteremic sepsis demonstrated by positive blood culture
  • Indwelling central and/or arterial venous access as per clinical indication.

Exclusion criteria

  • Patients with metabolic diseases (i.e.: urea cycle disorders, cystinuria, Insulin dependent diabetes mellitus, etc.).
  • Pregnancy.
  • Primary liver failure.

Healthy Children:

Inclusion criteria

  • Age 13-19 years.
  • Evidence of health as assessed by physical exam, and laboratory tests, including: Hematocrit no less than 36% for males and no less than 37% for females, white blood cell count from 5-10,000.
  • Chemistries within normal range, normal urine analysis, and fasting plasma glucose level no less than 60 or greater than 104 mg/dL.
  • Lean Children with BMI of 18-24.
  • Obese Children with BMI of 30 or greater.

Exclusion criteria

  • Tobacco use.
  • Pregnancy.
  • Taking any prescription medication that affects amino acid metabolism, i.e., glucocorticoids.
  • History of acute or chronic illness.

Treatment and study plan

Primary outcomes

  1. Gluconeogenesis Rates

    Time frame: 24 hours

    Rates of gluconeogenesis from glycerol, lactate/amino acids in relation to protein synthesis, breakdown and balance, and pyruvate cycling among different age groups (children vs. adolescents) and in comparison with healthy adolescents.

Secondary outcomes

  1. Metabolic Source for Gluconeogenesis

    Time frame: 24 hours during study and overall ICU admission

    Rates of gluconeogenesis from glycerol, lactate/amino acids in relation to severity of the disease, as determined by,

    • PRISM Score III, which is predictor of mortality in pediatric critically ill patients,
    • Degree of inflammation as assessed by plasma C reactive protein,
    • Highest inotrope doses and length of administration,
    • Ventilator-free days, ICU length of stay and length of hospital stay.

Other outcomes

  1. Length of ICU stay

    Time frame: 24 hours

Sponsors and collaborators

Lead sponsor

The Cleveland Clinic

Other

Collaborators

  • University of Texas

Registry information

Official study title

Gluconeogenesis Rates and Its Source in Critically Ill Adolescents

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Jul 2, 2013
Registry last updated
Apr 28, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.